TerrAscendTSNDF +2.79%32 FCF Margin % is 11.56% as of Mar. 2026. GuruFocus rates TSNDF with a GF Score™ of 32/100 and a GF Value™ of $0.99 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 958 Drug Manufacturers companies, TerrAscend ranks better than 58.14% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. TerrAscend's Free Cash Flow for the
three
months ended in Mar. 2026 was $7.6 Mil. TerrAscend's Revenue for the
three
months ended in Mar. 2026 was $65.5 Mil. Therefore, TerrAscend's FCF Margin % for the quarter that ended in Mar. 2026 was 11.56%.
The historical rank and industry rank for TerrAscend's FCF Margin % or its related term are showing as below:
TSNDF'
s FCF Margin % Range Over the Past 10 Years
Min: -554.25 Med: -32.27 Max: 11.15
Current: 5.64
During the past 10 years, the highest FCF Margin % of TerrAscend was 11.15%. The lowest was -554.25%. And the median was -32.27%.
TSNDF's FCF Margin % is ranked better than 58.14% of 958
companies
in the Drug Manufacturers industry
Industry Median: 2.51
vs TSNDF: 5.64
TerrAscend FCF Margin % Related Terms
TerrAscend FCF Margin % Historical Data
* Premium members only.
The historical data trend for TerrAscend's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, TerrAscend's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TerrAscend FCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, TerrAscend's FCF Margin % distribution charts can be found below:
* The bar in red indicates where TerrAscend's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TerrAscend (TSNDF) has a FCF Margin % of 11.56% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on TerrAscend and its competitors. According to the industry distribution chart, TerrAscend ranks #401 out of 958 companies in the Drug Manufacturers industry, placing it in the top 41.9%.
Is TerrAscend's FCF Margin % too high?
TerrAscend's current FCF Margin % is 11.56%. The Drug Manufacturers industry median FCF Margin % is 2.51. TerrAscend's value of 11.56% is 360.6% above this industry median. Based on the distribution chart, TerrAscend ranks #401 out of 958 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, TerrAscend has a GF Score™ of 32/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does TerrAscend's FCF Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, TerrAscend ranks #401 out of 958 companies for FCF Margin %. This puts TerrAscend in the upper half of its industry. The industry median FCF Margin % is 2.51. TerrAscend's value of 11.56% is 360.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.51, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. TerrAscend's current FCF Margin % of 11.56% is 360.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on TerrAscend and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TerrAscend's current FCF Margin % is 11.56%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TerrAscend stock overvalued right now?
Based on GuruFocus' analysis, TerrAscend (TSNDF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.99, compared to a current price of $0.65 — trading 34.8% below its estimated fair value. The current FCF Margin % is 11.56% and 360.6% above the Drug Manufacturers industry median of 2.51. TerrAscend's overall GF Score™ is 32/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For TerrAscend (TSNDF), the current FCF Margin % is 11.56% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is TerrAscend (TSNDF) Overvalued in 2026?
Based on GuruFocus' analysis, TerrAscend stock appears to be undervalued.
The current stock price of $0.65 is trading 34.8% below its estimated GF Value™ of $0.99.
GuruFocus considers TerrAscend to be Possible Value Trap.
Key valuation signals for TSNDF:
FCF Margin %: 11.56%
GF Value™: $0.99 vs. price of $0.65 (34.8% below fair value)
Industry Position: 360.6% above the Drug Manufacturers median (#401 of 958)
No single metric tells the full story. See the TSNDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
TerrAscend Corp is a company focused on creating and delivering cannabis products and services that meet the evolving needs of its patients. It also provides education and support programs to physicians and patients through healthcare professionals. In addition, the firm operates in California, Maryland, New Jersey, and Pennsylvania, with retail operations in Ohio and Canada. It operates The Apothecarium and other dispensary retail locations as well as scaled cultivation, processing, and manufacturing facilities in its core markets. The firm has one operating segment, being the cultivation, production, and sale of cannabis products, with subsidiaries located in Canada and the United States. The company generates key revenue from the United States.
32GF Score
Get the complete analysis for TSNDF
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSNDF has been successfully added to your 
